B S Shankaranarayana Rao
Overview
Explore the profile of B S Shankaranarayana Rao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
2778
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chowdhury A, Rao B, Laxmi T
Physiol Behav
. 2025 Jan;
292:114821.
PMID: 39862942
Previous studies suggest that early-life stress (ELS) induced by early maternal separation and isolation (MS) stress during the stress hyporesponsive period (SHRP) leads to increased curiosity-like and increased risky decision-making...
2.
Sasibhushana R, Rao B, Srikumar B
J Psychiatr Res
. 2024 Apr;
174:304-318.
PMID: 38685188
Finasteride, a 5α-Reductase inhibitor, is used to treat male pattern baldness and benign prostatic hyperplasia. Several clinical studies show that chronic finasteride treatment induces persistent depression, suicidal thoughts and cognitive...
3.
Chowdhury A, Sharma S, Arjun B, Pandya H, Rao B, Laxmi T
J Neurosci Methods
. 2023 Apr;
392:109864.
PMID: 37080434
One of the characteristic features of adolescence is risk-taking behavioural traits. Uncontrolled risk-taking without proper assessment may have harmful impact on mental health later in life. Therefore, it is essential...
4.
Mifepristone blocks the anxiolytic- and antidepressant-like effects of allopregnanolone in male rats
Choudhary D, Sasibhushana R, Rao B, Srikumar B
Int J Neurosci
. 2022 Dec;
134(8):839-848.
PMID: 36469636
Background: Allopregnanolone (3α, 5α-tetrahydroprogesterone) is an inhibitory neurosteroid synthesized from progesterone 5α-reductase activity in the brain and has anxiolytic, antidepressant, sedative, anticonvulsant, and analgesic activity. Altered levels of allopregnanolone cause...
5.
Fernandes V, Preeti K, Sood A, Nair K, Khan S, Rao B, et al.
Cell Mol Neurobiol
. 2022 Sep;
43(5):2005-2020.
PMID: 36138280
Chronic diabetic conditions have been associated with certain cerebral complications, that include neurobehavioral dysfunctional patterns and morphological alterations of neurons, especially the hippocampus. Neuroanatomical studies done by the authors have...
6.
Nayana J, Rao B, Srikumar B
Steroids
. 2022 Jun;
184:109058.
PMID: 35679911
Mifepristone is a non-selective progesterone (PR), glucocorticoid (GR), and androgen receptor (AR) antagonist with antidepressant and anxiolytic effects. The dose and duration of mifepristone administration vary in rodent preclinical studies...
7.
Subhadeep D, Srikumar B, Rao B, Kutty B
Neurosci Lett
. 2022 Feb;
776:136535.
PMID: 35182682
The subiculum, an important structure of the hippocampal formation, regulates spatial information processing, social cognition, and affective behavior. Earlier we demonstrated deficits in sociability and social novelty as a measure...
8.
Subhadeep D, Srikumar B, Rao B, Kutty B
Mol Neurobiol
. 2021 Oct;
58(12):6713.
PMID: 34626344
No abstract available.
9.
Subhadeep D, Srikumar B, Rao B, Kutty B
Mol Neurobiol
. 2021 May;
58(9):4437-4459.
PMID: 34024004
Ambient light influences our mood, behavior, and cognition. Phototherapy has been considered as an effective non-pharmacological intervention strategy in the restoration of cognitive functions following central nervous system insults. However,...
10.
Ahire A, Nair K, Rao B, Srikumar B
Psychoneuroendocrinology
. 2020 Nov;
124:105066.
PMID: 33249331
Objective: Neurosteroids are known to exert diverse functions in the brain. 5α-reductase (5α-R), a rate-limiting enzyme involved in the biosynthesis of neurosteroids is inhibited by finasteride. Clinical studies suggest that...